Haemonetics Corp. buy melinda
Start price
30.06.17
/
50%
€35.41
Target price
07.08.17
€38.34
Performance (%)
8.57%
End price
07.08.17
€38.45
Summary
This prediction ended on 07.08.17 with a price of €38.45. With a performance of 8.57%, the BUY prediction by melinda for Haemonetics Corp. closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Haemonetics Corp. | 1.493% | 1.493% | -18.072% | 27.103% |
iShares Core DAX® | 1.663% | 6.945% | 18.807% | 17.549% |
iShares Nasdaq 100 | 1.261% | 4.883% | 23.667% | 36.206% |
iShares Nikkei 225® | 0.654% | 10.007% | 15.047% | 9.552% |
iShares S&P 500 | 1.403% | 4.350% | 23.305% | 38.641% |
Comments by melinda for this prediction
In the thread Haemonetics Corp. diskutieren
Antikoagulans Natriumcitrat 4% w / v-Lösung, USP Haemonetics Corp.
$
(Zielkurs erreicht)
Stopped prediction by melinda for Haemonetics Corp.
Haemonetics Corp.
Start price
Target price
Perf. (%)
€66.50
09.08.20
09.08.20
€75.00
04.11.21
04.11.21
-7.52%
05.11.21
05.11.21
Haemonetics Corp.
Start price
Target price
Perf. (%)
€29.23
07.11.13
07.11.13
€32.00
07.05.14
07.05.14
-24.01%
07.05.14
07.05.14